GnRH receptors and GnRH endocrine effects on luteoma cells
An ovary implanted into the spleen of an ovariectomized rat develops into a luteinized tumor, growing in response to gonadotrophins. Previously, it was shown that in vivo Buserelin, a gonadotrophin-releasing hormone (GnRH) analog, inhibited tumor growth. To determine if GnRH had a direct effect on t...
Guardado en:
Publicado: |
1997
|
---|---|
Materias: | |
Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_1355008X_v6_n2_p165_ChamsonReig http://hdl.handle.net/20.500.12110/paper_1355008X_v6_n2_p165_ChamsonReig |
Aporte de: |
id |
paper:paper_1355008X_v6_n2_p165_ChamsonReig |
---|---|
record_format |
dspace |
spelling |
paper:paper_1355008X_v6_n2_p165_ChamsonReig2023-06-08T16:11:07Z GnRH receptors and GnRH endocrine effects on luteoma cells Buserelin effects Estradiol GnRH receptors Luteoma Progesterone buserelin estradiol gonadorelin receptor progesterone animal experiment animal model animal tissue article controlled study female luteoma nonhuman priority journal rat subcutaneous drug administration tumor cell Animals Antineoplastic Agents, Hormonal Buserelin Estradiol Estrus Female Gonadotropin-Releasing Hormone Iodine Radioisotopes Kinetics Luteoma Organ Culture Techniques Ovarian Neoplasms Progesterone Rats Rats, Sprague-Dawley Receptors, LHRH Superovulation Tumor Cells, Cultured An ovary implanted into the spleen of an ovariectomized rat develops into a luteinized tumor, growing in response to gonadotrophins. Previously, it was shown that in vivo Buserelin, a gonadotrophin-releasing hormone (GnRH) analog, inhibited tumor growth. To determine if GnRH had a direct effect on tumor cells, the presence of GnRH receptors as well as the endocrine effects of buserelin were studied on tumoral tissue. GnRH receptors were present in luteoma in similar concentrations and dissociation constant (Kd) to control estrous ovaries. In vivo treatment with buserelin did not modify luteoma GnRH receptors, In organ incubations, luteoma secreted significantly higher estradiol and lower progesterone than estrous ovaries; addition of buserelin did not modify steroid secretion. The same difference in basal steroid secretion between luteoma cells and luteal cells superovulated prepubertal ovaries was observed in cell cultures. Although luteinizing-hormone (LH)-stimulated progesterone in both kinds of cells, buserelin significantly inhibited LH-stimulated progesterone only in luteoma cells. These results describe clear differences in basal steroid secretion between tumoral and normal tissue. Furthermore, they show that luteoma possess GnRH receptors similar to those in normal ovarian tissue, and that GnRH analogs have endocrine effects on these cells. Therefore, a direct effect of buserelin on luteoma cells can be postulated. 1997 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_1355008X_v6_n2_p165_ChamsonReig http://hdl.handle.net/20.500.12110/paper_1355008X_v6_n2_p165_ChamsonReig |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
Buserelin effects Estradiol GnRH receptors Luteoma Progesterone buserelin estradiol gonadorelin receptor progesterone animal experiment animal model animal tissue article controlled study female luteoma nonhuman priority journal rat subcutaneous drug administration tumor cell Animals Antineoplastic Agents, Hormonal Buserelin Estradiol Estrus Female Gonadotropin-Releasing Hormone Iodine Radioisotopes Kinetics Luteoma Organ Culture Techniques Ovarian Neoplasms Progesterone Rats Rats, Sprague-Dawley Receptors, LHRH Superovulation Tumor Cells, Cultured |
spellingShingle |
Buserelin effects Estradiol GnRH receptors Luteoma Progesterone buserelin estradiol gonadorelin receptor progesterone animal experiment animal model animal tissue article controlled study female luteoma nonhuman priority journal rat subcutaneous drug administration tumor cell Animals Antineoplastic Agents, Hormonal Buserelin Estradiol Estrus Female Gonadotropin-Releasing Hormone Iodine Radioisotopes Kinetics Luteoma Organ Culture Techniques Ovarian Neoplasms Progesterone Rats Rats, Sprague-Dawley Receptors, LHRH Superovulation Tumor Cells, Cultured GnRH receptors and GnRH endocrine effects on luteoma cells |
topic_facet |
Buserelin effects Estradiol GnRH receptors Luteoma Progesterone buserelin estradiol gonadorelin receptor progesterone animal experiment animal model animal tissue article controlled study female luteoma nonhuman priority journal rat subcutaneous drug administration tumor cell Animals Antineoplastic Agents, Hormonal Buserelin Estradiol Estrus Female Gonadotropin-Releasing Hormone Iodine Radioisotopes Kinetics Luteoma Organ Culture Techniques Ovarian Neoplasms Progesterone Rats Rats, Sprague-Dawley Receptors, LHRH Superovulation Tumor Cells, Cultured |
description |
An ovary implanted into the spleen of an ovariectomized rat develops into a luteinized tumor, growing in response to gonadotrophins. Previously, it was shown that in vivo Buserelin, a gonadotrophin-releasing hormone (GnRH) analog, inhibited tumor growth. To determine if GnRH had a direct effect on tumor cells, the presence of GnRH receptors as well as the endocrine effects of buserelin were studied on tumoral tissue. GnRH receptors were present in luteoma in similar concentrations and dissociation constant (Kd) to control estrous ovaries. In vivo treatment with buserelin did not modify luteoma GnRH receptors, In organ incubations, luteoma secreted significantly higher estradiol and lower progesterone than estrous ovaries; addition of buserelin did not modify steroid secretion. The same difference in basal steroid secretion between luteoma cells and luteal cells superovulated prepubertal ovaries was observed in cell cultures. Although luteinizing-hormone (LH)-stimulated progesterone in both kinds of cells, buserelin significantly inhibited LH-stimulated progesterone only in luteoma cells. These results describe clear differences in basal steroid secretion between tumoral and normal tissue. Furthermore, they show that luteoma possess GnRH receptors similar to those in normal ovarian tissue, and that GnRH analogs have endocrine effects on these cells. Therefore, a direct effect of buserelin on luteoma cells can be postulated. |
title |
GnRH receptors and GnRH endocrine effects on luteoma cells |
title_short |
GnRH receptors and GnRH endocrine effects on luteoma cells |
title_full |
GnRH receptors and GnRH endocrine effects on luteoma cells |
title_fullStr |
GnRH receptors and GnRH endocrine effects on luteoma cells |
title_full_unstemmed |
GnRH receptors and GnRH endocrine effects on luteoma cells |
title_sort |
gnrh receptors and gnrh endocrine effects on luteoma cells |
publishDate |
1997 |
url |
https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_1355008X_v6_n2_p165_ChamsonReig http://hdl.handle.net/20.500.12110/paper_1355008X_v6_n2_p165_ChamsonReig |
_version_ |
1768545941793538048 |